Abstract
Introduction and Aim: A recent European Liver Transplant registry study showed that the proportion of liver transplants performed for nonalcoholic steatohepatitis (NASH) in Europe has increased from 2002 through 2016, and that the post-transplant outcome in patients with NASH is comparable to that of other disease indications. There are few data on recent trends in waiting list inscriptions/dynamics, and on intention-to-treat transplant survival of NASH patients, however.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
